Information about GlobalPharmacyMeds.to
List of countries where we can ship Esbriet:
Latest news releases on Esbriet:
Learn about Esbriet® (pirfenidone), a medicine for treating idiopathic pulmonary fibrosis, a progressive and irreversible fibrotic interstitial lung disease.
European Union agency responsible for the protection of public and animal health through the scientific evaluation and supervision of medicines.
Esbriet (pirfenidone) is used to treat Idiopathic Pulmonary Fibrosis. Includes Esbriet side effects, interactions and indications.
Learn about Esbriet (Pirfenidone Capsules) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.
Pirfenidone; Clinical data; Trade names: Esbriet, Pirespa, Etuary: AHFS/Drugs.com: International Drug Names: License data
Whether you are starting a new medicine or have been taking it for a period of time, it is important to know about certain side effects and how to best manage them.
Esbriet está indicado en adultos para el tratamiento de la fibrosis pulmonar idiopática (FPI) de leve a moderada.
Esbriet 267 mg Hard Capsules - Summary of Product Characteristics (SPC) by Roche Products (Ireland) Ltd
Esbriet 267 mg Hard Capsules - Summary of Product Characteristics (SPC) by Roche Products Limited
Esbriet® was originally funded in 2014 under EAP Criteria that restricted coverage to patients with moderate IPF, that is, with FVC% between 50-80%.